White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu OA, Dondorp AM. Malaria. Lancet 2014;383:723-35. [Ref.ID 97151]

Whitty CJM, Chiodini PL, Lalloo DG. Investigation and treatment of imported malaria in non-endemic countries. BMJ 2013;346:31-4. [Ref.ID 95545]

Friedrich MJ. Artemisinin-resistant malaria. JAMA 2012;307:2017. [Ref.ID 93065]

Phyo A, Nikhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, Ier Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NPJ, White NJ, Anderson TJC, Nosten F. Emergence of artemisin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 2012;379:1960-6. [Ref.ID 93060]

Watts G. Use artesunate not quinine to treat severe malaria, say experts. BMJ 2011;342:947. [Ref.ID 90692]

Dondorp AM, Fanello CI, von Seidlein L, Day NPJ, White NJ. Artesunate for severe malaria in African children. Authors' reply. Lancet 2011;377:1154. [Ref.ID 90356]

Obaro SK. Artesunate for severe malaria in African children. Lancet 2011;377:1153-4. [Ref.ID 90355]

Fortin A, Verbeeck RK, Jansen FH. Comparative oral bioavailability of non-fixed and fixed combinations of artesunate and amodiaquine in healthy Indian male volunteers. Eur J Clin Pharmacol 2011;67:267-75. [Ref.ID 90097]

Tozan Y, Klein EY, Darley S, Panicker R, Laxminarayan R, Breman JG. Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis. Lancet 2010;376:1910-5. [Ref.ID 89760]

Dondorp AM, Hendriksen ICE, Gomes E, Seni A, Chhaganlal K, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin O, Johnson WBR, Tshefu A, Onyamboko MA, Sakulthaew T, Ngum WP, Silamut K, Stepniewska K, Woodrow CJ, Bethell D, Wills B, Oneko M, Peto TE, von Seidlein L, Day NPJ, White NJ, for the AQUAMAT group. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010;376:1647-57. [Ref.ID 89325]

Shetty P. Bernard Pécoul: championing the cause of neglected diseases. Lancet 2010;376:677. [Ref.ID 89245]

Anónimo. Artésunate en suppositoire. Une option dans le paludisme grave. La Lettre du CEDIM 2010;13:14. [Ref.ID 88574]

Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SSS, Bustos DG, Tjitra E, Bedu-Addo G, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L, and the Pyronaridine-artesunate Study Team. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial. Lancet 2010;375:1457-67. [Ref.ID 88419]

Nosten FH. Pyronaridine-artesunate for uncomplicated falciparum malaria. Lancet 2010;375:1413-4. [Ref.ID 88412]

Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009;361:455-67. [Ref.ID 86433]

Aronson JK. Routes of drug administration: uses and adverse effects. Part 2: sublingual, buccal, rectal, and some other routes. Adv Drug React Bull 2009;254:975-8. [Ref.ID 85536]

Gomes MF, Faiz MA, Gyapong JO, Warsame M, Agbenyega T, Babiker A, Baiden F, Yunus EB, Binka F, Clerk C, Folb P, Hassan R, Hossain MA, Kimbute O, Kitua A, Krishna S, Makasi C, Mensah N, Mrango Z, Olliaro P, Peto R, Peto TJ, Rahman MR, Ribeiro I, Samad R, White NJ, for the Study 13 Research Group. Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet 2009;373:557-66. [Ref.ID 85283]

von Seidlein L, Deen JL. Pre-referral rectal artesunate in severe malaria. Lancet 2009;373:522-3. [Ref.ID 85272]

Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J, for the Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008;135:1924-34. [Ref.ID 84961]

Anónimo. Enrichir sa panoplie thérapeutique. Bilan de l'année 2008. Maladies infectieuses (hors HIV). Prescrire 2009;29:41-2. [Ref.ID 84816]